Treffer 1 - 5 von 5 für Suche 'Scionti, Katrin', Suchdauer: 0,50s Treffer weiter einschränken
  1. 1
    New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy

    New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy von Scionti, Katrin, Molyneux, Karen, Selvaskandan, Haresh, Barratt, Jonathan, Cheung, Chee Kay

    Veröffentlicht in Glomerular diseases

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    FC050: Nefecon® Selectively Modifies the Composition of Circulating Immune Complexes in IGA Nephropathy

    FC050: Nefecon® Selectively Modifies the Composition of Circulating Immune Complexes in IGA Nephropathy von Molyneux, Karen, Scionti, Katrin, Wolski, Witold, Pfammatter, Sibylle, Kunz, Laura, Mannaa, Atef, Barratt, Jonathan


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Reduction of Urinary Levels of Lectin Pathway Complement Components in an IgA Vasculitis Patient After MASP-2 Inhibition with Narsoplimab: PO1590

    Reduction of Urinary Levels of Lectin Pathway Complement Components in an IgA Vasculitis Patient After MASP-2 Inhibition with Narsoplimab: PO1590 von Alós, Laura Pérez, Scionti, Katrin, Molyneux, Karen, Barratt, Jonathan, Garred, Peter


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial

    Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial von Wimbury, David, Muto, Masahiro, Bhachu, Jasraj S., Scionti, Katrin, Brown, Jeremy, Molyneux, Karen, Seikrit, Claudia, Maixnerová, Dita, Pérez-Alós, Laura, Garred, Peter, Floege, Jürgen, Tesař, Vladimír, Fellstrom, Bengt, Coppo, Rosanna, Barratt, Jonathan

    Veröffentlicht in Kidney international

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  5. 5
    Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy : insights from the NEFIGAN trial

    Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy : insights from the NEFIGAN trial von Wimbury, David, Muto, Masahiro, Bhachu, Jasraj S, Scionti, Katrin, Brown, Jeremy, Molyneux, Karen, Seikrit, Claudia, Maixnerová, Dita, Pérez-Alós, Laura, Garred, Peter, Floege, Jürgen, Tesar, Vladimír, Fellström, Bengt, Coppo, Rosanna, Barratt, Jonathan

    Volltext bestellen
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: